Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-04 Sale |
2025-03-06 6:55 pm |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
5,000 | $115.03 | $575,149 | 59,080 (Direct) |
View |
| 2024-12-23 Sale |
2024-12-26 8:32 pm |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
2,104 | $116.37 | $244,850 | 20,647 (Direct) |
View |
| 2024-11-27 Sale |
2024-12-02 8:05 pm |
LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director |
2,406 | $123.65 | $297,502 | 29,515 (Direct) |
View |
| 2024-09-23 Sale |
2024-09-25 8:54 pm |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary |
2,000 | $99.6 | $199,201 | 93,478 (Direct) |
View |
| 2024-09-20 Sale |
2024-09-24 7:41 pm |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,275 | $103.94 | $132,518 | 24,610 (Direct) |
View |
| 2024-09-20 Sale |
2024-09-24 7:41 pm |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
16,047 | $102.35 | $1,642,359 | 93,608 (Direct) |
View |
| 2024-08-28 Sale |
2024-08-30 8:56 pm |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary |
1,500 | $106.39 | $159,591 | 83,978 (Direct) |
View |
| 2024-08-22 Sale |
2024-08-26 8:15 pm |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
18,858 | $105.34 | $1,986,420 | 49,510 (Direct) |
View |
| 2024-08-09 Sale |
2024-08-13 5:21 pm |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
18,245 | $98.5 | $1,797,133 | 68,368 (Direct) |
View |
| 2024-08-08 Purchase |
2024-08-09 5:52 pm |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
2,500 | $97.39 | $243,481 | 123,010 (Direct) |
View |
| 2024-05-09 Sale |
2024-05-17 8:00 pm |
LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director |
934 | $83.2 | $77,713 | 5,633 (Direct) |
View |
| 2024-05-15 Sale |
2024-05-17 7:59 pm |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
13,293 | $86.26 | $1,146,704 | 65,530 (Direct) |
View |
| 2024-05-13 Sale |
2024-05-15 7:34 pm |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & Chief Operating |
17,598 | $84.99 | $1,495,740 | 86,263 (Direct) |
View |
| 2024-05-09 Sale |
2024-05-13 5:32 pm |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew Chief Legal Officer & |
10,000 | $83.04 | $830,449 | 85,149 (Direct) |
View |
| 2024-03-05 Sale |
2024-03-07 1:27 pm |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
1,893 | $74.3 | $140,650 | 29,345 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-01 Exercise |
2025-04-16 09:34 am |
N/A 2025-04-24 |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
2,406 | $0 | 32,584 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-16 09:34 am |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
2,406 | $52.3 | 32,584 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-06 6:55 pm |
N/A 2035-03-04 |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary |
34,458 | $0 | 62,826 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-06 6:55 pm |
N/A 2035-03-04 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
40,201 | $0 | 59,080 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-06 6:54 pm |
N/A 2035-03-04 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
114,858 | $0 | 245,200 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-19 8:44 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
20,784 | $0 | 130,342 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-19 8:44 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
13,452 | $120 | 130,342 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-19 8:38 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
12,819 | $0 | 23,879 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-19 8:38 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
9,587 | $120 | 23,879 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-19 8:37 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary |
12,357 | $0 | 28,368 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-19 8:37 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary |
6,523 | $120 | 28,368 (Direct) |
View |
| 2024-12-05 Tax Withholding |
2024-12-06 7:55 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,859 | $123.51 | 22,751 (Direct) |
View |
| 2024-11-27 Exercise |
2024-12-02 8:05 pm |
N/A 2025-04-24 |
LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director |
2,406 | $0 | 29,515 (Direct) |
View |
| 2024-11-27 Exercise |
2024-12-02 8:05 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director |
2,406 | $52.3 | 29,515 (Direct) |
View |
| 2024-09-23 Exercise |
2024-09-25 8:54 pm |
N/A 2032-08-01 |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary |
2,000 | $0 | 93,478 (Direct) |
View |
| 2024-09-23 Exercise |
2024-09-25 8:54 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary |
2,000 | $52.27 | 93,478 (Direct) |
View |
| 2024-09-20 Exercise |
2024-09-24 7:41 pm |
N/A 2026-02-11 |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
14,754 | $0 | 93,608 (Direct) |
View |
| 2024-09-20 Exercise |
2024-09-24 7:41 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
5,377 | $49.99 | 93,608 (Direct) |
View |
| 2024-09-23 Exercise |
2024-09-24 7:41 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
9,377 | $52.84 | 93,608 (Direct) |
View |
| 2024-09-17 Exercise |
2024-09-19 5:50 pm |
N/A 2030-10-01 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,486 | $0 | 33,591 (Direct) |
View |
| 2024-09-17 Exercise |
2024-09-19 5:50 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,417 | $80.72 | 33,591 (Direct) |
View |
| 2024-09-17 Exercise |
2024-09-19 5:50 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
69 | $57.22 | 33,591 (Direct) |
View |
| 2024-09-16 Exercise |
2024-09-18 7:55 pm |
N/A 2026-02-11 |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
5,774 | $0 | 114,348 (Direct) |
View |
| 2024-09-16 Tax Withholding |
2024-09-18 7:55 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
3,214 | $105 | 114,348 (Direct) |
View |
| 2024-09-16 Exercise |
2024-09-18 7:55 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
671 | $49.99 | 114,348 (Direct) |
View |
| 2024-09-16 Exercise |
2024-09-18 7:55 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
3,340 | $60.94 | 114,348 (Direct) |
View |
| 2024-09-16 Exercise |
2024-09-18 7:55 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
914 | $55.75 | 114,348 (Direct) |
View |
| 2024-09-16 Exercise |
2024-09-18 7:55 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
849 | $58.49 | 114,348 (Direct) |
View |
| 2024-08-28 Exercise |
2024-08-30 9:00 pm |
N/A 2030-10-01 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
753 | $0 | 31,708 (Direct) |
View |
| 2024-08-28 Exercise |
2024-08-30 9:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
546 | $70.04 | 31,708 (Direct) |
View |
| 2024-08-28 Exercise |
2024-08-30 9:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
207 | $57.22 | 31,708 (Direct) |
View |
| 2024-08-28 Exercise |
2024-08-30 8:56 pm |
N/A 2032-08-01 |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary |
1,500 | $0 | 83,978 (Direct) |
View |
| 2024-08-28 Exercise |
2024-08-30 8:56 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary |
1,500 | $52.27 | 83,978 (Direct) |
View |
| 2024-06-28 Other |
2024-07-02 7:45 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew Chief Legal Officer & |
329 | $60.71 | 22,863 (Direct) |
View |
| 2024-06-28 Other |
2024-07-02 7:45 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & Chief Operating |
350 | $60.71 | 86,963 (Direct) |
View |
| 2024-06-28 Other |
2024-07-02 7:45 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
267 | $60.71 | 23,913 (Direct) |
View |
| 2024-06-28 Other |
2024-07-02 7:44 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
350 | $60.71 | 120,860 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-25 7:45 pm |
N/A 2034-06-14 |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
6,696 | $0 | 35,622 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-18 9:27 pm |
N/A 2034-06-14 |
LIGAND PHARMACEUTICALS INC | LGND | Zimmermann Martine Director |
6,696 | $0 | 8,981 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-18 9:27 pm |
N/A 2034-06-14 |
LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director |
6,696 | $0 | 34,959 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-18 9:26 pm |
N/A 2034-06-14 |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
6,696 | $0 | 49,219 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-18 9:26 pm |
N/A 2034-06-14 |
LIGAND PHARMACEUTICALS INC | LGND | Haas Jason Director |
6,696 | $0 | 10,841 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-18 9:26 pm |
N/A 2034-06-14 |
LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director |
6,696 | $0 | 12,329 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-18 9:25 pm |
N/A 2034-06-14 |
LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director |
6,696 | $0 | 140,143 (Direct) |
View |
| 2024-05-17 Exercise |
2024-05-17 7:59 pm |
N/A 2030-10-01 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
6,917 | $0 | 65,530 (Direct) |
View |
| 2024-05-17 Exercise |
2024-05-17 7:59 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
145 | $68.74 | 65,530 (Direct) |
View |
| 2024-05-17 Exercise |
2024-05-17 7:59 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,544 | $63.62 | 65,530 (Direct) |
View |
| 2024-05-17 Exercise |
2024-05-17 7:59 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
206 | $57.22 | 65,530 (Direct) |
View |
| 2024-05-17 Exercise |
2024-05-17 7:59 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
5,022 | $52.84 | 65,530 (Direct) |
View |
| 2024-05-09 Exercise |
2024-05-13 5:32 pm |
N/A 2032-08-01 |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew Chief Legal Officer & |
10,000 | $0 | 85,149 (Direct) |
View |
| 2024-05-09 Exercise |
2024-05-13 5:32 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew Chief Legal Officer & |
10,000 | $52.27 | 85,149 (Direct) |
View |
| 2024-04-30 Exercise |
2024-05-02 6:07 pm |
N/A 2025-04-24 |
LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director |
2,406 | $0 | 133,447 (Direct) |
View |
| 2024-04-30 Exercise |
2024-05-02 6:07 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director |
2,406 | $52.3 | 133,447 (Direct) |
View |
| 2024-04-24 Exercise |
2024-04-26 6:35 pm |
N/A 2024-06-04 |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
2,893 | $0 | 42,523 (Direct) |
View |
| 2024-04-24 Exercise |
2024-04-26 6:35 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
2,893 | $39.35 | 42,523 (Direct) |
View |
| 2024-03-25 Exercise |
2024-03-27 5:47 pm |
N/A 2032-06-10 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
16,015 | $0 | 120,160 (Direct) |
View |
| 2024-03-25 Exercise |
2024-03-27 5:47 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
2,156 | $68.51 | 120,160 (Direct) |
View |
| 2024-03-25 Exercise |
2024-03-27 5:47 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
3,556 | $66.19 | 120,160 (Direct) |
View |
| 2024-03-25 Exercise |
2024-03-27 5:47 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
2,855 | $67.24 | 120,160 (Direct) |
View |
| 2024-03-25 Exercise |
2024-03-27 5:47 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
7,448 | $46.2 | 120,160 (Direct) |
View |
| 2024-03-05 Exercise |
2024-03-07 1:27 pm |
N/A 2024-06-04 |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
2,893 | $0 | 29,345 (Direct) |
View |
| 2024-03-05 Exercise |
2024-03-06 5:28 pm |
N/A 2024-06-04 |
LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director |
2,893 | $0 | 131,041 (Direct) |
View |
| 2024-03-05 Exercise |
2024-03-06 5:28 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director |
2,893 | $39.35 | 131,041 (Direct) |
View |